Lezoche Emanuele, Baldarelli Maddalena, De Sanctis Angelo, Lezoche Giovanni, Guerrieri Mario
Department of Surgery Paride Stefanini, II Clinica Chirurgica, University La Sapienza, Rome, Italy.
Dig Dis. 2007;25(1):76-9. doi: 10.1159/000099173.
Local excision of rectal cancer is an alternative to radical resection but today its role surrounding the management of patients with early stage rectal cancer (T1-T2-N0) represents an important surgical issue.
To analyze the results of 135 patients with early stage low rectal cancer treated with local excision by transanal endoscopic microsurgery and in the case of T2 also by neoadjuvant therapy.
135 patients with T1-T2-N0-M0 rectal cancer were enrolled in the study. Staging according to the definitive histological findings was as follows: pT0 in 24 patients (17.8%), pT1 in 66 patients (48.8%) and pT2 in 45 patients (33.4%).
Minor complications were observed in 12 patients (8.8%) whereas major complications were seen only in 2 patients (1.5%). At a median follow-up of 78 (36-125) months, local recurrences occurred in 4 patients and distal metastasis in 2 patients (all patients were staged preoperatively T2). Disease-free survival rates in T1 and T2 patients were 100 and 93% respectively at the end of follow-up.
With respect to local recurrence and survival rate, the long-term results of early stage rectal cancer in patients treated with transanal endoscopic microsurgery were similar to those reported in the literature after conventional surgery (total mesorectal excision).
直肠癌局部切除是根治性切除的一种替代方法,但如今其在早期直肠癌(T1-T2-N0)患者管理中的作用仍是一个重要的外科问题。
分析135例早期低位直肠癌患者经肛门内镜显微手术进行局部切除的结果,对于T2期患者还分析新辅助治疗的结果。
135例T1-T2-N0-M0直肠癌患者纳入本研究。根据最终组织学检查结果分期如下:24例患者(17.8%)为pT0,66例患者(48.8%)为pT1,45例患者(33.4%)为pT2。
12例患者(8.8%)出现轻微并发症,而仅2例患者(1.5%)出现严重并发症。中位随访78(36-125)个月时,4例患者发生局部复发,2例患者发生远处转移(所有术前分期为T2的患者)。随访结束时,T1和T2患者的无病生存率分别为100%和93%。
就局部复发和生存率而言,经肛门内镜显微手术治疗的早期直肠癌患者的长期结果与传统手术(全直肠系膜切除)文献报道的结果相似。